Summary
Metformin has no effect on diastolic function following acute myocardial infarction (MI) in nondiabetic patients. The disappointing finding from the Glycometabolic Interventions in Patients Presenting With ST-Segment Elevation Myocardial Infarction trial [GIPS-III; Lexis CP et al. JAMA 2014] is discussed in this article.
- Myocardial Infarction
- Cardiology Clinical Trials
- Cardiology & Cardiovascular Medicine
- Myocardial Infarction
- Cardiology Clinical Trials
- © 2014 MD Conference Express®